21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia.
Nimkarn S, Gangishetti PK, Yau M, New MI.
2002 Feb 26 [updated 2016 Feb 4]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
[Congenital adrenal hyperplasia].
Stanić M, Nesović M.
Med Pregl. 1999 Nov-Dec;52(11-12):447-54.
Ethnic and National Differences in Congenital Adrenal Hyperplasia Incidence: A Systematic Review and Meta-Analysis.
Navarro-Zambrana AN, Sheets LR.
Horm Res Paediatr. 2023;96(3):249-258. doi: 10.1159/000526401. Epub 2022 Aug 16.
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood.
White PC, Bachega TA.
Semin Reprod Med. 2012 Oct;30(5):400-9. doi: 10.1055/s-0032-1324724. Epub 2012 Oct 8.
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency.
Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Macut D.
Front Endocrinol (Lausanne). 2019 Jul 4;10:432. doi: 10.3389/fendo.2019.00432. eCollection 2019.
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
White PC, Speiser PW.
Endocr Rev. 2000 Jun;21(3):245-91. doi: 10.1210/edrv.21.3.0398.
Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia).
New MI.
Am J Med. 1995 Jan 16;98(1A):2S-8S. doi: 10.1016/s0002-9343(99)80052-7.
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
Speiser PW.
Endocrinol Metab Clin North Am. 2001 Mar;30(1):31-59, vi. doi: 10.1016/s0889-8529(08)70018-5.
[Salt wasting syndrome caused by congenital, insufficient synthesis or aldosterone function--etiology, diagnosis and management].
Basiak A, Wikiera B, Noczyńska A.
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(2):103-8.
Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.
J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):19-29. doi: 10.1016/s0960-0760(99)00059-x.
